NEW YORK, Nov. 4 (GenomeWeb News) - Molecular Devices today said it has settled a patent infringement lawsuit filed by Caliper Technologies in 2002 involving Molecular Devices' IMAP kinase assay products.
Under the terms of the settlement, Molecular Devices has agreed to pay Caliper a one-time licensing fee as well as royalties based on future sales of IMAP products.
Further details of the settlement were not disclosed.
The lawsuit alleged that Molecular Devices' IMAP assay products infringed Caliper's US Patent Nos. 6,287,774 and 6,472,141, which cover methods and systems for performing assays in which the reaction product has a different charge than the substrate. The product or substrate is bound to a polyionic component, and the binding is detected by conventional methods, including fluorescence polarization.